Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Rev Mal Respir Retrieve available abstracts of 26 articles: HTML format

Single Articles

May 2025
1. GROSZ T, Calcaianu G, Palpacuer C, Riou M, et al
   [Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].
   Rev Mal Respir. 2025;42:243-251.
   PubMed     Abstract available
   
   
   March 2025
2. CHARPIN D, Brun O
   [Wildfires and their respiratory impact].
   Rev Mal Respir. 2025;42:159-167.
   PubMed     Abstract available
   
   
   
3. MAZENQ J, Dubus JC, Chanez P, Gras D, et al
   [Post-infectious bronchiolitis obliterans in children: A rare and potentially devastating disease].
   Rev Mal Respir. 2025;42:148-152.
   PubMed     Abstract available
   
   
   February 2025
4. BERGEREAU H, Hassoun D, Marquant Q, Rousselle M, et al
   [Impact of Rac1 activation on eosinophil degranulation in severe asthma].
   Rev Mal Respir. 2025 Feb 26:S0761-8425(25)00049.
   PubMed     Abstract available
   
   
   January 2025
5. TEULIER M, Fouquereau E, Bremond M, Courtois R, et al
   [Psychosocial traits associated with maintenance of physical activity 12months after a pulmonary rehabilitation program - An exploratory study].
   Rev Mal Respir. 2025;42:38-47.
   PubMed     Abstract available
   
   
   December 2024
6. MERIENNE A, Claude Roux P, Chassagne A
   [Understanding teenagers' experiences of asthma. A qualitative approach to adolescents' perceptions of the disease and management of the symptoms].
   Rev Mal Respir. 2024 Dec 10:S0761-8425(24)00340.
   PubMed     Abstract available
   
   
   
7. SANDOT A, Bunel V, Mal H
   [Indications of home oxygen therapy for patients with COPD or ILD].
   Rev Mal Respir. 2024;41:751-761.
   PubMed     Abstract available
   
   
   
8. ROCHE N, Bernady A, Piperno D, Bachiri A, et al
   [Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].
   Rev Mal Respir. 2024;41:715-726.
   PubMed     Abstract available
   
   
   
9. DOURNES G, Zysman M, Benlala I, Berger P, et al
   [CT imaging of chronic obstructive pulmonary disease: What aspects and what role?].
   Rev Mal Respir. 2024;41:738-750.
   PubMed     Abstract available
   
   
   November 2024
10. REGARD L, Lazureanu PC, Pascal B, Laurichesse G, et al
    [Efficacy and toxicity of short-course corticosteroid therapy in chronic bronchial diseases].
    Rev Mal Respir. 2024;41:696-712.
    PubMed     Abstract available
    
    
    October 2024
11. THIBAUT DE MENONVILLE C, Barakat L, Laborier F, Le Brun M, et al
    [Efficacy of biologics for severe asthma on allergic comorbidities].
    Rev Mal Respir. 2024 Oct 4:S0761-8425(24)00274-2. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available
    
    
    September 2024
12. MARGUET C, Gregoire, Werner A, Cracco O, et al
    [Management of asthma attack in children aged 6 to 12 years].
    Rev Mal Respir. 2024 Sep 9:S0761-8425(24)00246-8. doi: 10.1016/j.rmr.2024.
    PubMed    
    
    
    
13. BEYDON N, Abou Taam R, Delclaux C, Du Boisbaudry C, et al
    [Pulmonary function test: The testing of children].
    Rev Mal Respir. 2024;41:488-497.
    PubMed     Abstract available
    
    
    
14. RUELLAND C, Beaumont M
    [Effects of gender on pulmonary rehabilitation outcomes in patients with COPD].
    Rev Mal Respir. 2024;41:463-471.
    PubMed     Abstract available
    
    
    
15. GIRAULT C, Artaud-Macari E, Jolly G, Carpentier D, et al
    [High-flow nasal oxygen therapy and hypercapnic acute respiratory failure].
    Rev Mal Respir. 2024;41:498-507.
    PubMed     Abstract available
    
    
    August 2024
16. LEJEUNE S, Hullo E, Bierme P, Baravalle M, et al
    [From difficult-to-treat asthma to severe asthma: Step 5].
    Rev Mal Respir. 2024 Aug 26:S0761-8425(24)00245.
    PubMed    
    
    
    June 2024
17. ROCHE N, Caron A, Emery C, Torreton E, et al
    [Medico-economic evaluation of the PRADO-BPCO post-exacerbation support program].
    Rev Mal Respir. 2024;41:409-420.
    PubMed     Abstract available
    
    
    
18. ALEXANDRE F, Molinier V, Poulain M, Villiot-Danger E, et al
    [French survey of patients on current and future pulmonary rehabilitation programs].
    Rev Mal Respir. 2024;41:399-408.
    PubMed     Abstract available
    
    
    May 2024
19. DESLEE G, Le Rouzic O, Zysman M, Roche N, et al
    [Second COPD biennial of the French Society of Respiratory Diseases: Major changes].
    Rev Mal Respir. 2024;41:329-330.
    PubMed    
    
    
    
20. ANCEL J, Chen E, Pavot A, Regard L, et al
    [Take-home messages from the 2nd COPD 2023 Biennial of the French Society of Respiratory Diseases. Placing the patient at the center of the care pathway].
    Rev Mal Respir. 2024;41:331-342.
    PubMed     Abstract available
    
    
    
21. JESTIN-GUYON N, Raherison-Semjen C
    [Pesticide exposure and chronic respiratory diseases].
    Rev Mal Respir. 2024;41:343-371.
    PubMed     Abstract available
    
    
    April 2024
22. DARGENTOLLE G, Georges M, Beltramo G, Poisson C, et al
    [Adverse events in biologics for severe asthma].
    Rev Mal Respir. 2024 Apr 22:S0761-8425(24)00190.
    PubMed     Abstract available
    
    
    
23. RAASCH K, Dupin I
    [Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics].
    Rev Mal Respir. 2024;41:269-273.
    PubMed     Abstract available
    
    
    March 2024
24. JUSTEAU G, Toigo M, Castro de Freitas T, Ribeiro Baptista B, et al
    [Pulmonary lipofibroblasts in adults and alveolar regeneration in emphysema].
    Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00145-1. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available
    
    
    
25. AHMED E, Assou S, Foisset F, Bourdais C, et al
    [Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC)].
    Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00142-6. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available
    
    
    February 2024
26. GADDOUR A, Chatti S, Chouchene A, Kacem I, et al
    [An epidemiological and evolutionary profile of occupational asthma of Tunisian workers].
    Rev Mal Respir. 2024 Feb 29:S0761-8425(24)00116.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.